Progress of immune response and immune therapy in HBV-infected patientsWANG Fu-sheng, ZHANG Ji-yuan193-198
Research progress of dendritic cell-based vaccine in the treatment of liver diseasesWU Xue-jie, WANG Gui-qiang203-205,210
Reference ranges of peripheral blood lymphocyte subset percentages in hepatitis B virus-infected Chinese populationZHANG Zheng, FU Jun-liang, ZHOU Chun-bao, ZHANG Hui, JIN Lei, LI Qing-hong, L(U) Ji-yun, WANG Fu-sheng206-210
Correlation between increased pro-inflammatory CD16+ monocytes and severity of liver injury and fibrosis in patients with chronic hepatitis BWANG Lu-jun, L(U) Ji-yun, ZHANG Ji-yuan, ZOU Zheng-sheng, ZHANG Zheng, CHEN Li-ming, LI Bao-sen, WANG Fu-sheng211-214
Predictable value of dynamic changes of serum thymosin β4 on prognosis in patients with chronic liver failureLIU Ying, HAN Tao, ZHU Zheng-yan, LIU Hua, GUO Zhen, LI Ying, XIAO Shi-xiang, LI Yan215-223
Influence of artificial liver support system on Th1/Th2 and Tc1/Tc2 subsets in patients with chronic severe hepatitis BMAO Yan-qun, CHEN Kai-hong, PEI Hao218-220,256
Role of hepatocyte apoptosis and apoptosis-related genes Caspase-3 and Bcl-2 in the pathogenesis of chronic severe hepatitis BGUO Xiao-dong, HU Jin-hua, DUAN Xue-zhang, XIONG Lu, LIU Shu-hong, LIU Chun-lian, ZHOU Guang-de, ZHAO Yu-lai, ZHAO Jing-min221-223
Thirty-two critically ill patients with pandemic 2009 influenza A (H1N1) unaccompanied by underlying diseasesJIANG Rong-meng, WANG Xiao-jie, XU Yan-li, WANG Yan-bin, HUANGFU Jing-kun, WANG Jing-jing, ZHANG Wei, JIAO Yi-qing, GUO Li-min, CHEN Zhi-hai224-228
Clinical significance of CD3+ T lymphocytemonocyte ratio in patients with acute-on-chronic liver failureGENG Hua, L(U) Ji-yun, ZHANG Ji-yuan, CHEN Li-ming, L(U) Sa, WANG Fu-sheng229-232